Skip to main content

Table 2 Mean (sd) utility measures by presence of diabetes-related complications at baseline

From: Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial

  % of study population Utilities
   Dolan (EQ-5D) Shaw (EQ-5D) Brazier SF-6D (SF12) Brazier SF-6D (SF36) Lundberg (SF-12) Lawrence (SF12-MEPS) Franks (SF12-MEPS) Franks (SF12) Fryback (SF36v1)
All patients 100% (n = 975) 0.801 (0.206) 0.848 (0.144) 0.780 (0.131) .746 (0.138) 0.801 (0.103) 0.728 (0.182) .725 (0.189) 0.744 (0.186) 0.678 (0.079)
MEDICAL CONDITION           
Stroke and/or TIA Y 10.5% .708 (0.259) .783 (0.174) .744 (0.141) .700 (0.142) .762 (0.112) .659 (0.192) .650 (0.207) .666 (0.211) .648 (0.082)
  N .812 (0.196) .856 (0.138) .784 (0.129) .751 (0.136) .804 (0.102) .736 (0.179) .734 (0.185) .754 (0.181) .682 (0.078)
Peripheral Revascularization and/or Amputation Y 5.4% .722 (0.236) .793 (0.159) .730 (0.149) .698 (0.146) .751 (0.116) .646 (0.207) .633 (0.232) .643 (0.250) .638 (0.078)
  N .805 (0.204) .851 (0.143) .782 (0.129) .749 (0.137) .803 (0.102) .733 (0.179) .730 (0.185) .750 (0.180) .681 (0.079)
Hospital admin for unstable Angina Y 12.6% .741 (0.242) .805 (0.165) .739 (0.148) .703 (0.146) .768 (0.116) .661 (0.198) .654 (0.214) .678 (0.222) .655 (0.083)
  N .809 (0.199) .854 (0.140) .785 (0.127) .752 (0.137) .804 (0.101) .737 (0.177) .735 (0.184) .754 (0.179) .682 (0.078)
Myocardial Infarction Y 18.8% .767 (0.223) .826 (0.152) .764 (0.136) .732 (0.138) .778 (0.105) .695 (0.182) .692 (0.195) .715 (0.200) .665 (0.078)
  N .808 (0.202) .853 (0.142) .783 (0.130) .749 (0.138) .805 (0.103) .736 (0.181) .732 (0.188) .751 (0.182) .682 (0.079)
Coronary artery bypass graft Y 18.6% .788 (0.211) .839 (0.146) .769 (0.136) .736 (0.140) .788 (0.107) .710 (0.185) .706 (0.198) .727 (0.205) .673 (0.082)
  N .804 (0.205) .850 (0.144) .782 (0.130) .748 (0.137) .803 (0.102) .732 (0.181) .729 (0.187) .748 (0.182) .680 (0.079)
Currently treated Hypertension Y 64.7% .789 (0.209) .839 (0.145) .769 (0.132) .735 (0.137) .794 (0.102) .710 (0.181) .707 (0.190) .728 (0.189) .670 (0.078)
  N .823 (0.199) .865 (0.141) .798 (0.127) .767 (0.138) .814 (0.103) .763 (0.178) .759 (0.184) .775 (0.177) .694 (0.080)
Diabetic Eye Disease incl. Blindness in either eye Y 7.6% .801 (0.177) .848 (0.126) .769 (0.131) .732 (0.142) .779 (0.105) .697 (0.190) .690 (0.202) .710 (0.199) .669 (0.073)
  N .801 (0.208) .848 (0.145) .780 (0.131) .747 (0.138) .801 (0.103) .731 (0.181) .728 (0.188) .747 (0.185) .679 (0.080)
Patients without above conditions at baseline 21.5% .843 (0.186) .877 (0.135) .802 (0.125) .771 (0.137) .824 (0.098) .778 (0.174) .774 (0.177) .788 (0.165) .701 (0.079)
Duration of Diabetes >= 5 yrs 47.3% .808 (0.208) .853 (0.146) .782 (0.133) .750 (0.141) .796 (0.105) .726 (0.185) .722 (0.193) .740 (0.191) .678 (0.082)
  6+ yrs 52.7% .793 (0.205) .843 (0.142) .777 (0.129) .743 (0.135) .802 (0.102) .730 (0.179) .727 (0.186) .748 (0.182) .679 (0.077)